Browse
related articles
UAE to curb Tamiflu use
- United Arab Emirates: Sunday, October 11 - 2009 at 10:03
The UAE's health authorities are considering stopping the administering of an anti-viral drug to all suspected cases of H1N1, as unnecessary consumption of the drug may lead to resistance against the virus in the body, Khaleej Times has reported. The decision will be based on the reviewed recommendations by the World Health Organisation that suggest that the drug should only be administered to patients from the high-risk group, including children, pregnant women and the elderly or to patients (not from the high-risk category) whose H1N1 tests have confirmed the case.
Also consider reading:
Today's top stories
Week's top stories
Digg
Facebook
LinkedIn
Twitter
Browse
related articles
- » Ford 2011 Mustang to have new engine
- » Dubai World: Official statement on debt obligations
- » Moody's: Dubai World restructuring unlikely to threaten sovereign credit of UAE and Abu Dhabi
- » Dubai World to restructure $26bn Nakheel, Limitless debt
- » More than $147bn committed to development of the Middle East's road, rail and public transport infrastructure
StaffSunday, October 11 - 2009 at 10:03 UAE local time (GMT+4)
Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.
Disclaimer:
The information comprised in this section is not, nor is it held out to be, a solicitation of any person to take any form of investment decision. The content of the AMEinfo.com Web site does not constitute advice or a recommendation by AME Info FZ LLC / Emap Limited and should not be relied upon in making (or refraining from making) any decision relating to investments or any other matter. You should consult your own independent financial adviser and obtain professional advice before exercising any investment decisions or choices based on information featured in this AMEinfo.com Web site.
AME Info FZ LLC / Emap Limited can not be held liable or responsible in any way for any opinions, suggestions, recommendations or comments made by any of the contributors to the various columns on the AMEinfo.com Web site nor do opinions of contributors necessarily reflect those of AME Info FZ LLC / Emap Limited.
In no event shall AME Info FZ LLC / Emap Limited be liable for any damages whatsoever, including, without limitation, direct, special, indirect, consequential, or incidental damages, or damages for lost profits, loss of revenue, or loss of use, arising out of or related to the AMEinfo.com Web site or the information contained in it, whether such damages arise in contract, negligence, tort, under statute, in equity, at law or otherwise.
It looks like you are using a Mac - check out our 
Web Feeds